# Axon Enterprise share price today (Axon Enterprise, Inc., AXON)

> Axon Enterprise, Inc.'s share price has risen faster than its earnings: −43.1% in a year, against −68.5% for earnings per share. AXON · Industrials · Aerospace & Defense · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/axon

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $416.57 (−43.1% in a year)
- P/E: 173.3× (higher than 68% of the last 4.6 years)
- Revenue (Jun 2026): $904 M (+35.3% on a year ago)
- Profit (Jun 2026): $29.4 M (−18.5% on a year ago)
- Operating margin: 5.2% (+5.4 points on a year ago)
- ROE: 4%, FY25
- ROIC: 1.2%, against a 11.9% cost of capital: −10.7 points

The main question: the share price moved −43.1% in a year while yearly earnings per share moved −68.5%. The difference came from the market paying a higher multiple. ## What is the Axon Enterprise share price today? Axon Enterprise, Inc.'s share price was $416.57 at the close on 3 November 2026. It has been falling for 9 weeks. That is 12.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between $346 and $636, and at that close it sat 24% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 7 weeks running. Over the last 10 years the share price moved +1,426% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 18 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Axon Enterprise pay? Axon Enterprise, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Axon Enterprise on? Axon Enterprise is on 2 of our US lists: Nasdaq 100 companies and S&P 500 companies. - [Nasdaq 100 companies](https://www.sectoralpha.in/nasdaq-100-stocks)
- [S&P 500 companies](https://www.sectoralpha.in/sp-500-stocks)

## Is Axon Enterprise profitable? Axon Enterprise, Inc. earned $29.4 M of net profit in the Jun 2026 quarter, −18.5% on the same quarter a year earlier. Full-year FY25 profit was $125 M. That is 3.3% of the quarter's revenue. The same quarter a year earlier earned $36.1 M. 1 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $125 M (−66.9% on the year before). Why profit moved: revenue changed +35.3% on a year earlier and the margin moved +5.4 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed −31.9% and revenue +34.5%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Axon Enterprise make, and is it growing? Axon Enterprise, Inc. reported $904 M of revenue in the Jun 2026 quarter, +35.3% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 33.9% a year on average. The last full year, FY25, came in at $2.8 B. The last four reported quarters add to $3.2 B. FY25 revenue was $2.8 B, +33.5% on the year before. Recent pace: the last four quarters grew +34.5% on average, against 33.9% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +34.6%, against +33.5% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −38.9%, against −17.6% a year (rolling over). ## How much of every $100 of sales does Axon Enterprise keep? Axon Enterprise, Inc.'s operating margin was 5.2% in the Jun 2026 quarter, 5.4 percentage points higher than the same quarter a year ago. Across 5 years it has been between −19.5% and 10.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +5.4 percentage points on the year while gross margin changed −0.1 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Axon Enterprise's profit turning into cash? Over the last 3 years, 119% of Axon Enterprise, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $211 M of operating cash against $125 M of profit. After $136 M of spending on assets, $75.1 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Axon Enterprise's cash go? Axon Enterprise, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $275 M on assets over the last 3 years. Averaged over those years that is 3.3% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $275 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Axon Enterprise's P/E ratio, and how does it compare with its own history? Axon Enterprise, Inc.'s P/E is 173.3×, in the middle of its own history: higher than 68% of past readings. Its usual P/E (the middle reading) is 135.0×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −68.5% while the price moved −43.1%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved +24.2% a year; about +6.8% a year came from earnings growth and about +17.4 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Axon Enterprise business getting better or worse? Axon Enterprise, Inc.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −38.9% in the latest quarter, against +196.6% at its best in 12 quarters, with ROCE steady at -0.8%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Axon Enterprise earn on its capital? Axon Enterprise, Inc. earned a ROE of 4% in FY25. That is up from a low of −6% in FY21. Its return on capital used (ROIC) is 10.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 4.5% net margin and 0.40× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 4.5% net margin × 0.40× asset turnover × 2.16× leverage (assets divided by equity) ≈ 3.9% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 1.2% − 11.9% = −10.7 percentage points. The 11.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 1.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at −1.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Axon Enterprise have too much debt? Axon Enterprise, Inc. has total debt of $1.9 B against shareholder equity of $3.7 B as of Jun 2026, so its debt is 0.50× its equity. Year by year, that ratio went from 0.03 in FY21 to 0.59 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Axon Enterprise shareholding pattern? 5.3% of Axon Enterprise, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Axon Enterprise from balance-sheet trouble? For Axon Enterprise, Inc., the Z-score is 8.18. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 8.18 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Axon Enterprise rank in its industry? 36.7 out of 100, rank 24 of 30 in Aerospace & Defense, with 71% of the evidence available. Axon Enterprise, Inc. scores 36.7 out of 100 against the 30 companies it is compared with in Aerospace & Defense, ranking 24. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 18.2 + 6.3 + 8.6 + 3.6 = 36.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Axon Enterprise compared with? Axon Enterprise ranks 24 of 30 Aerospace & Defense companies on the 4-Factor Sector Score, with 36.7 out of 100. 1. [Lockheed Martin Corporation](https://www.sectoralpha.in/us/stocks/lmt) LMT · turning · Most evidence points up · 85% evidence 76.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Revenue 7.9% · Profit 55.1% · Operating margin change -0.3 points · 95% evidence Capital efficiency 18.7/25 · ROCE 21.5% · Operating margin 11.4% · 76% evidence Valuation 16.0/20 · P/E 18.4× · PEG 0.32 · 65% evidence Relative strength 20.0/20 · Lead over its industry 21.2% · Lead over S&P 500 9.2% · 1 year 39.4% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.9 + 18.7 + 16 + 20 = 76.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Woodward, Inc.](https://www.sectoralpha.in/us/stocks/wwd) WWD · quiet · Most evidence points up · 81% evidence 67.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.9/35 · Revenue 22.4% · Profit 42.9% · Operating margin change 4.7 points · 83% evidence Capital efficiency 18.1/25 · ROCE 18.1% · Operating margin 17.8% · 76% evidence Valuation 12.9/20 · P/E 45.9× · PEG 1.09 · 65% evidence Relative strength 8.9/20 · Lead over its industry 0.2% · Lead over S&P 500 -9.6% · 1 year 24.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.9 + 18.1 + 12.9 + 8.9 = 67.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [HEICO Corporation](https://www.sectoralpha.in/us/stocks/hei) HEI · basing · Most evidence points up · 85% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 20.7% · Profit 31.9% · Operating margin change 2 points · 95% evidence Capital efficiency 16.4/25 · ROCE 14% · Operating margin 25.1% · 76% evidence Valuation 10.1/20 · P/E 48.9× · PEG 1.56 · 65% evidence Relative strength 16.3/20 · Lead over its industry 11% · Lead over S&P 500 0.5% · 1 year 4.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 24.4 + 16.4 + 10.1 + 16.3 = 67.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [RTX Corporation](https://www.sectoralpha.in/us/stocks/rtx) RTX · quiet · Evidence leans up · 85% evidence 63.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.8/35 · Revenue 11.6% · Profit 27.6% · Operating margin change 3.2 points · 95% evidence Capital efficiency 12.8/25 · ROCE 11.1% · Operating margin 15.5% · 76% evidence Valuation 13.1/20 · P/E 29.8× · PEG 1.12 · 65% evidence Relative strength 14.9/20 · Lead over its industry 11.3% · Lead over S&P 500 0.6% · 1 year 15.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 22.8 + 12.8 + 13.1 + 14.9 = 63.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Howmet Aerospace Inc.](https://www.sectoralpha.in/us/stocks/hwm) HWM · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.9/35 · Revenue 18.1% · Profit 34% · Operating margin change 3.5 points · 83% evidence Capital efficiency 21.0/25 · ROCE 22.7% · Operating margin 28.5% · 76% evidence Valuation 9.3/20 · P/E 57.5× · PEG 1.61 · 65% evidence Relative strength 4.7/20 · Lead over its industry -1.9% · Lead over S&P 500 -11.3% · 1 year 8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25.9 + 21 + 9.3 + 4.7 = 60.9 · What this means: Earnings are strong; relative strength in its sector is -1.9% and the one-year return is 8%. 6. [General Dynamics Corporation](https://www.sectoralpha.in/us/stocks/gd) GD · quiet · Too little evidence to rank firmly · 58% evidence 58.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.4/35 · Revenue n/a · Profit n/a · Operating margin change -0.1 points · 45% evidence Capital efficiency 13.9/25 · ROCE 13.7% · Operating margin 10.4% · 76% evidence Valuation 10.9/20 · P/E 22.5× · PEG n/a · 15% evidence Relative strength 17.2/20 · Lead over its industry 11.4% · Lead over S&P 500 0.9% · 1 year 8.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.4 + 13.9 + 10.9 + 17.2 = 58.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Elbit Systems Ltd.](https://www.sectoralpha.in/us/stocks/eslt) ESLT · quiet · Evidence leans up · 81% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 13.7% · Profit 58.2% · Operating margin change 1.6 points · 83% evidence Capital efficiency 11.5/25 · ROCE 10.7% · Operating margin 9.6% · 76% evidence Valuation 12.1/20 · P/E 55.9× · PEG 1.1 · 65% evidence Relative strength 11.7/20 · Lead over its industry 8.3% · Lead over S&P 500 -2.4% · 1 year 61.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.4 + 11.5 + 12.1 + 11.7 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Leonardo DRS, Inc.](https://www.sectoralpha.in/us/stocks/drs) DRS · quiet · Evidence leans up · 81% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.8/35 · Revenue 10.5% · Profit 28.8% · Operating margin change 2.8 points · 83% evidence Capital efficiency 13.8/25 · ROCE 12.8% · Operating margin 11.2% · 76% evidence Valuation 11.7/20 · P/E 35.4× · PEG 1.33 · 65% evidence Relative strength 10.4/20 · Lead over its industry 0.8% · Lead over S&P 500 -9.2% · 1 year 10% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.8 + 13.8 + 11.7 + 10.4 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Huntington Ingalls Industries, Inc.](https://www.sectoralpha.in/us/stocks/hii) HII · turning · Evidence leans up · 81% evidence 55.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue 14% · Profit 25.9% · Operating margin change 0.5 points · 83% evidence Capital efficiency 8.9/25 · ROCE 8.4% · Operating margin 7.1% · 76% evidence Valuation 16.0/20 · P/E 16.7× · PEG 0.65 · 65% evidence Relative strength 10.9/20 · Lead over its industry -0.1% · Lead over S&P 500 -10.7% · 1 year 2.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.3 + 8.9 + 16 + 10.9 = 55.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Loar Holdings Inc.](https://www.sectoralpha.in/us/stocks/loar) LOAR · basing · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.7/35 · Revenue 29.9% · Profit 53.3% · Operating margin change 1.2 points · 83% evidence Capital efficiency 9.4/25 · ROCE 6.6% · Operating margin 26.2% · 76% evidence Valuation 7.6/20 · P/E 111× · PEG 1.96 · 65% evidence Relative strength 16.3/20 · Lead over its industry 7.7% · Lead over S&P 500 -2.6% · 1 year -8.2% · 100% evidence · 2 of 12 weeks ahead Exact sum: 19.7 + 9.4 + 7.6 + 16.3 = 53 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Hexcel Corporation](https://www.sectoralpha.in/us/stocks/hxl) HXL · quiet · Evidence leans up · 85% evidence 52.7 out of 100 Growth Capital Valuation Relative
12. [TransDigm Group Incorporated](https://www.sectoralpha.in/us/stocks/tdg) TDG · turning · Evidence leans up · 81% evidence 52.3 out of 100 Growth Capital Valuation Relative
13. [Textron Inc.](https://www.sectoralpha.in/us/stocks/txt) TXT · turning · Too little evidence to rank firmly · 58% evidence 51.6 out of 100 Growth Capital Valuation Relative
14. [StandardAero, Inc.](https://www.sectoralpha.in/us/stocks/saro) SARO · basing · Evidence leans up · 71% evidence 51.5 out of 100 Growth Capital Valuation Relative
15. [Northrop Grumman Corporation](https://www.sectoralpha.in/us/stocks/noc) NOC · basing · Evidence leans up · 85% evidence 51.0 out of 100 Growth Capital Valuation Relative
16. [Embraer S.A.](https://www.sectoralpha.in/us/stocks/embj) EMBJ · leader · Evidence leans down · 81% evidence 49.1 out of 100 Growth Capital Valuation Relative
17. [L3Harris Technologies, Inc.](https://www.sectoralpha.in/us/stocks/lhx) LHX · basing · Evidence leans down · 68% evidence 47.9 out of 100 Growth Capital Valuation Relative
18. Honeywell Aerospace Inc. HONA · quiet · Too little evidence to rank firmly · 51% evidence 47.5 out of 100 Growth Capital Valuation Relative
19. [GE Aerospace](https://www.sectoralpha.in/us/stocks/ge) GE · basing · Evidence leans down · 85% evidence 47.4 out of 100 Growth Capital Valuation Relative
20. [Curtiss-Wright Corporation](https://www.sectoralpha.in/us/stocks/cw) CW · basing · Evidence leans down · 81% evidence 46.2 out of 100 Growth Capital Valuation Relative
21. [FTAI Aviation Ltd.](https://www.sectoralpha.in/us/stocks/ftai) FTAI · quiet · Evidence leans down · 81% evidence 43.8 out of 100 Growth Capital Valuation Relative
22. [CAE Inc.](https://www.sectoralpha.in/us/stocks/cae) CAE · turning · Evidence leans down · 71% evidence 43.2 out of 100 Growth Capital Valuation Relative
23. [Rocket Lab Corporation](https://www.sectoralpha.in/us/stocks/rklb) RKLB · quiet · Evidence leans down · 64% evidence 41.0 out of 100 Growth Capital Valuation Relative
24. Axon Enterprise, Inc. this page AXON · basing · Evidence leans down · 71% evidence 36.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 34.6% · Profit -39% · Operating margin change 5.4 points · 83% evidence Capital efficiency 6.3/25 · ROCE 0.8% · Operating margin 5.2% · 76% evidence Valuation 8.6/20 · P/E 226.7× · PEG n/a · 15% evidence Relative strength 3.6/20 · Lead over its industry -10.7% · Lead over S&P 500 -19.4% · 1 year -30.9% · 100% evidence · 3 of 12 weeks ahead Exact sum: 18.2 + 6.3 + 8.6 + 3.6 = 36.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 25. [The Boeing Company](https://www.sectoralpha.in/us/stocks/ba) BA · quiet · Evidence leans down · 64% evidence 36.4 out of 100 Growth Capital Valuation Relative
26. [BWX Technologies, Inc.](https://www.sectoralpha.in/us/stocks/bwxt) BWXT · basing · Evidence leans down · 81% evidence 35.9 out of 100 Growth Capital Valuation Relative
27. [AeroVironment, Inc.](https://www.sectoralpha.in/us/stocks/avav) AVAV · quiet · Most evidence points down · 67% evidence 34.8 out of 100 Growth Capital Valuation Relative
28. [Kratos Defense & Security Solutions, Inc.](https://www.sectoralpha.in/us/stocks/ktos) KTOS · quiet · Most evidence points down · 71% evidence 32.7 out of 100 Growth Capital Valuation Relative
29. [Moog Inc.](https://www.sectoralpha.in/us/stocks/mog-b) MOG-B · Too little evidence to rank firmly · 36% evidence 60.2 out of 100 Growth Capital Valuation Relative
30. Space Exploration Technologies Corp. SPCX · breaking out · Too little evidence to rank firmly · 38% evidence 43.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Aerospace & Defense](https://www.sectoralpha.in/us/sectors/aerospace-defense), all 30 compared on one page. ## Which companies are close to Axon Enterprise in size? Axon Enterprise is the 12th largest of 61 Aerospace & Defense companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: L3Harris Technologies, Inc., HEICO Corporation and Elbit Systems. Just below it: Rocket Lab Corporation, FTAI Aviation and Woodward, Inc. ### Aerospace & Defense companies close in size

1. [L3Harris Technologies, Inc.](https://www.sectoralpha.in/us/stocks/lhx) $51.7 billion
2. [HEICO Corporation](https://www.sectoralpha.in/us/stocks/hei) $47.2 billion
3. [Elbit Systems Ltd.](https://www.sectoralpha.in/us/stocks/eslt) $35.4 billion
4. Axon Enterprise, Inc. $33.8 billion
5. [Rocket Lab Corporation](https://www.sectoralpha.in/us/stocks/rklb) $32.6 billion
6. [FTAI Aviation Ltd.](https://www.sectoralpha.in/us/stocks/ftai) $20.5 billion
7. [Woodward, Inc.](https://www.sectoralpha.in/us/stocks/wwd) $19.6 billion

[All 61 Aerospace & Defense companies, largest first](https://www.sectoralpha.in/us/sectors/aerospace-defense#all-companies)

### Companies close in size in other industries

1. [JD.com, Inc.](https://www.sectoralpha.in/us/stocks/jd) $35.3 billion · Internet Retail
2. [TKO Group Holdings, Inc.](https://www.sectoralpha.in/us/stocks/tko) $35 billion · Entertainment
3. Axon Enterprise, Inc. $34.6 billion
4. [The Hershey Company](https://www.sectoralpha.in/us/stocks/hsy) $34.4 billion · Confectioners
5. [Zoetis Inc.](https://www.sectoralpha.in/us/stocks/zts) $34.4 billion · Drug Manufacturers - Specialty & Generic

## What else do people ask about Axon Enterprise? ### What were Axon Enterprise's latest quarterly results? Axon Enterprise, Inc. reported revenue of $904 M and net profit of $29.4 M for the Jun 2026 quarter. Revenue rose 35.3% and profit fell 18.5% compared with a year earlier. Earnings per share were $0.36. The operating margin was 5.2%, 5.4 percentage points higher than a year earlier (as of 3 November 2026). ### What is Axon Enterprise's market cap? Axon Enterprise, Inc.'s market capitalisation is $33.8 B at a stock price of $416.57. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Axon Enterprise performing? Axon Enterprise, Inc.'s share price has been falling for 9 weeks. In its latest quarter, revenue rose 35.3% and profit fell 18.5% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 7 weeks running (as of 3 November 2026). ### Will Axon Enterprise's stock price go up? This page does not forecast Axon Enterprise, Inc.'s stock price. What it shows instead: the stock price is $416.57, and it has been falling for 9 weeks. Its P/E of 173.3× is higher than 68% of its own last 5 years (as of 3 November 2026). ### Where is Axon Enterprise in its business cycle? Axon Enterprise, Inc.'s FY25 operating margin was −1.1%, against a 5-year range of −19.5% to 10.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 5.2%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Axon Enterprise story? The main question: the share price moved −43.1% in a year while yearly earnings per share moved −68.5%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Axon Enterprise a stock worth studying right now? What the numbers show: Axon Enterprise, Inc.'s share price has risen faster than its earnings: −43.1% in a year, against −68.5% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- Nasdaq 100 companies: https://www.sectoralpha.in/nasdaq-100-stocks
- S&P 500 companies: https://www.sectoralpha.in/sp-500-stocks

This is research, not advice. We’re not SEBI-registered.